Results 301 to 310 of about 1,411,950 (341)
Some of the next articles are maybe not open access.
2003
The pharmaceutical industry is no longer the “analysts’ darling” — quite the reverse is true. The industry is currently facing increasing pressure due to the lack of innovateon and productivity in drug research and development (Fig. 1, global R&D productivity trend 1991–2001).
J, Reinhard-Rupp, G, Wess
openaire +2 more sources
The pharmaceutical industry is no longer the “analysts’ darling” — quite the reverse is true. The industry is currently facing increasing pressure due to the lack of innovateon and productivity in drug research and development (Fig. 1, global R&D productivity trend 1991–2001).
J, Reinhard-Rupp, G, Wess
openaire +2 more sources
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly
Drug Discovery Paradigms: Target-Based Drug Discovery
2022Chonny Herrera-Acevedo +4 more
openaire +1 more source
2019
Modern chemistry foundations were made in between the 18th and 19th centuries and have been extended in 20th century. R&D towards synthetic chemistry was introduced during the 1960s. Development of new molecular drugs from the herbal plants to synthetic chemistry is the fundamental scientific improvement.
openaire +1 more source
Modern chemistry foundations were made in between the 18th and 19th centuries and have been extended in 20th century. R&D towards synthetic chemistry was introduced during the 1960s. Development of new molecular drugs from the herbal plants to synthetic chemistry is the fundamental scientific improvement.
openaire +1 more source
Cancer epigenetics in clinical practice
Ca-A Cancer Journal for Clinicians, 2023Veronica Davalos, Manel Esteller
exaly
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly